Grown Rogue International (GRUSF) Gross Profit Growth (1y) (2012 - 2026)
Grown Rogue International (GRUSF) Gross Profit Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 5.06% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 2.59% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -18.38% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | -7.66% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -0.34% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 42.12% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 14.77% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | 17.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.66% |
| Dec 31, 2025 | -61,477,219.00% |
| Sep 30, 2025 | 124,576,033.33% |
| Jun 30, 2025 | 93,252,025,519,628.59% |
| Mar 31, 2025 | 3.26% |
| Dec 31, 2024 | 458.59% |
| Jan 31, 2023 | 8.85% |
| Jan 31, 2022 | 725.41% |
| Oct 31, 2021 | 490.62% |
| Jul 31, 2021 | 291.66% |
| Apr 30, 2021 | 552.39% |
| Jan 31, 2021 | -57.13% |
| Oct 31, 2020 | 375.72% |
| Jul 31, 2020 | -28.89% |
| Apr 30, 2020 | 638.78% |
| Jan 31, 2020 | 154.96% |
| Oct 31, 2019 | 47.36% |
| Jul 31, 2019 | 130.11% |
| Apr 30, 2019 | 79.91% |
| Jan 31, 2019 | 181.58% |